Eledon Pharmaceuticals, Inc (ELDN)

Etorro trading 970x250
Eledon Pharmaceuticals, Inc (ELDN) Logo

About Eledon Pharmaceuticals, Inc

Eledon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company’s lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. Address: 19900 MacArthur Boulevard, Irvine, CA, United States, 92612

Eledon Pharmaceuticals, Inc News and around…

Latest news about Eledon Pharmaceuticals, Inc (ELDN) common stock and company :

Eledon Pharmaceuticals Announces Presentation on AT-1501 at the Virtual 2021 Northeast Amyotrophic Lateral Sclerosis Consortium
07 Oct, 2021 Yahoo! Finance

IRVINE, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), announced their participation in the Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) which is being held virtually on October 7, 2021. Dr. Steve Perrin, Eledo

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Eledon Pharmaceuticals Announces Upcoming Presentation on AT-1501 at the Virtual 2021 International Pancreas and Islet Transplantation Association Congress
05 Oct, 2021 Yahoo! Finance

IRVINE, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), announced an upcoming presentation on AT-1501, its lead clinical candidate, at the International Pancreas and Islet Transplantation Association (IPITA) Congress, which i

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
30 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Eledon Pharmaceuticals to Present at Two Investor Conferences in September
01 Sep, 2021 FinancialContent
How The Parts Add Up: ITOT Targets $112
19 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Core S&P Total US.

Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
12 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
12 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

Eledon Pharmaceuticals to Release Second Quarter Financial Results on Thursday, August 12, 2021
02 Aug, 2021 FinancialContent

Management to host conference call and webcast at 4:30 pm ET

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
29 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Eledon Pharmaceuticals Receives Health Canada Approval to Commence Human Trials to Evaluate AT-1501 in Kidney Transplantation
26 Jul, 2021 FinancialContent
Analysts Predict 36% Upside For The Holdings of IWC
14 Jul, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Micro-Cap ETF (IWC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $199.62 per unit.

Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of Directors
02 Jul, 2021 FinancialContent
Eledon Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference
29 Jun, 2021 FinancialContent
Read This Before Selling Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Shares
27 Jun, 2021 Yahoo! Finance

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

Eledon Pharmaceuticals is Now Oversold (ELDN)
10 Jun, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
07 Jun, 2021 FinancialContent

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical ...

Analysts Predict 10% Gains Ahead For The Holdings of ITOT
21 May, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Core S&P Total US.

Eledon Pharmaceuticals to Present at the 2021 Jefferies Virtual Healthcare Conference
18 May, 2021 FinancialContent
Eledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results
13 May, 2021 FinancialContent
Eledon Pharmaceuticals, Inc. to Host Earnings Call
13 May, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
13 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
09 May, 2021 FinancialContent

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical ...

Eledon Pharmaceuticals Announces Upcoming Presentations on AT-1501 at the Virtual 2021 American Transplant Congress
05 May, 2021 FinancialContent
Eledon Pharmaceuticals to Release First Quarter Financial Results on Thursday, May 13, 2021
04 May, 2021 FinancialContent

Management to host conference call and webcast at 4:30 pm ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
27 Apr, 2021 FinancialContent

Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market ...

Eledon Pharma Stock Jumps Despite FDA Asking For Additional Preclinical Study In Non-Primate Animal Models
27 Apr, 2021 FinancialContent

As part of ongoing discussions with the FDA regardingEledon Pharmaceuticals Inc's(NASDAQ:ELDN) AT-1501 renal ...

Eledon Pharmaceuticals, Inc (ELDN) is a NASDAQ Common Stock listed in , ,

970x250